Key points are not available for this paper at this time.
A continuous-flow left ventricular assist device can provide effective hemodynamic support for a period of at least 6 months in patients awaiting heart transplantation, with improved functional status and quality of life. (ClinicalTrials.gov number, NCT00121472 ClinicalTrials.gov.).
Building similarity graph...
Analyzing shared references across papers
Loading...
Leslie W. Miller
Brigham and Women's Hospital
Francis D. Pagani
Heart Failure & Transplant
Stuart D. Russell
Heart Failure & Transplant
New England Journal of Medicine
University of Michigan
Columbia University
Massachusetts General Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Miller et al. (Wed,) studied this question.
synapsesocial.com/papers/69effab7bce9831ba4f73c82 — DOI: https://doi.org/10.1056/nejmoa067758
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: